WARNING: This site deals only with the corporate corruption of science, and makes no inference about the motives or activities of individuals involved.
    There are many reasons why individuals become embroiled in corporate corruption activities - from political zealotry to over-enthusiastic activism; from gullibility to greed.
    Please read the OVERVIEW carefully, and make up your own mind.

OPINION ONLY

Some key documents

• Stephen C Littlechild, PhD., Professor of Commerce, and Head of the Department of Industrial Economics and Business Studies, Faculty of Commerce and Social Science, University of Birmingham, England.

• Uni of Birmingham in the UK. He worked with J Wiseman

1981 May 18: -19 He is at the Wharton Applied Research Center Conference, University of Philadelphia. He presents a paper "Advertising, Brand Loyalty and Habit". The proceedings were published in "Analysis of Consumer Policy".

1981 Dec 30.: George Berman, of Devon Management Resources, has written to Richard Marcotullio as the current chairman of the SAWP group at INFOTAB. [Berman and DMR Inc. act as contractors and provide cover for INFOTAB operations] He reports that Professor Littlechild has submitting a book proposal [with himself as editor]:

Professor Littlechild has submitted the enclosed outline of a book or monograph which might "take the offensive" , rather than merely rebut the social-cost argument. In concept, this would be similar to a book by Bruce Biggs, called The War Against the Automobile, except that Dr. Littlechild has outlined a more thoughtful, less polemic approach.

    I believe this could be a vehicle for putting together everything we have been doing for the last three years, and then some.

    Should the book be perceived as a criticism of smoking policy, or as a criticism of consumer policy, with smoking as the central illustration? One of the problems which arises throughout the outline is the concept of "smoking and related products". From the industry's standpoint, it may not be acceptable to join the smoking issue with such other topics as alcohol abuse, motorcycle helmets or infant formula. Nevertheless, if an offensive stance is to be taken, as Dr. Littlechild suggests, the arguments must have a broader basis than just smoking or they will appear trivial and self-serving.

[Copies of this document are sent to US tobacco lawyer Tim Finnegan, and Andrew Whist, head of Corporate Affairs at Philip Morris International.]

1982 May 13-14: the Advisory Group of INFOTAB (the main disinformation executives) were meeting in Washington DC. These points emerge:

• Expenses of these meetings are being charge to "general consultancy fees of Ogilvy and Mather"
• Mr Don Hoel stated that the possibility of presenting evidence from witnesses from other countries before the US Congressional Hearings (e.g. Waterson, Littlechild) gives a broader scope to the industry's argumentation, and is no doubt a notable result of INFOTAB's activities.

1983 Apr 5: The Tobacco Institute, through Shook Hardy & Bacon has been organising scientific responses to Congressman Thomas Bliley's (R-VA tobacco friendly Representative) queries. This memo details what should and should not be included in the package to Bliley. Some of the replies have apparently been unsatisfactory. He is on the list along with about 31 other shonky scientists. All are well-known and well-documented tobacco industry lackeys.

[Obviously Bliley has written to the list of scientists supplied by the Tobacco Institute. A note questions whether he actually got a letter from Bliley]

1983 May 5: —12 Tobacco Institute witnesses before a range of Congressional Committees and Subcommittees in the period 1982-83. All 39 scientists presented testimony against proposals of the Comprehensive Smoking Prevention Education Act (1982) and similar legislation introduced in the House and Senate in 1983.

1. Domingo M. Aviado, M.D., president, Atmospheric Health Sciences, Inc.; adjunct professor of pharmacology, University of Medicine and Dentistry of New Jersey, Newark
2. Rodger L Bick, M.D., medical director, San Joaquin Hematology and Oncology Medical Group; assistant professor of medicine, School of Medicine, UCLA Center for the Health Sciences, Los Angeles
3. Richard J. Bing, M.D., professor of medicine emeritus, University of Southern California; director of experimental cardiology, Huntington. Medical Research Institutes, Pasadena -
4. Theodore H. Blau, Ph.D., private practice of clinical and child psychology, Tampa
5. Walter M. Booker, Ph.D., professor emeritus of pharmacology, Howard University College of Medicine, Washington, D.C.; president, Walter M. Booker & Associates, Inc., Washington, D.C.
6. Oliver Gilbert Brooke. M.D., FRCP, Head of Neonatology, Department of Child Health, St.George's Hospital Medical School, University of London, England
7. Barbara B. Brown, Ph.D., former chief of experimental physiology, Veterans Administration Hospital, Sepulveda, Cal.
8. Victor B. Buhler, M.D., pathologist, Liberty Hospital, Liberty, Mo.
9. P R. J. Burch, Ph.D., professor. department of medical physics, University of Leeds, England (The evidence of Prof. Burch is to be found in the Congressional Record of August 11, 1982, pp. 3830-32.)
10. Hans J. Eysenck, Ph.D., D.Sc., professor of psychology, Institute of Psychiatry, University of London, England
11. Jack Mathews Farris, M.D., emeritus professor of surgery, University of California, San Diego
12. Sherwin J. Feinhandler, Ph.D., former lecturer in anthropology, Harvard Medical School; president, Social Systems Analysts, Inc., Watertown, Mass.
13. Edwin R. Fisher, M.D., professor of pathology, University of Pittsburgh School of Medicine; director of laboratories, Shadyside Hospital, Pittsburgh
14. H. Russell Fisher, M.D., emeritus professor of pathology, University of Southern California; consultant, Memorial Hospital, Glendale, Cal.
15. Arthur Furst, Ph.D., distinguished university professor (emeritus) and director (emeritus), Institute of Chemical Biology, University of San Francisco, San Francisco.
16. Jean D. Gibbons, Ph.D., professor of statistics, chairman of applied statistics program, Graduate School, University of Alabama
17. Katherine McDermott Herrold, M.D., medical director (retired), U.S. Public Health Service, Washington, D.C.
18. Richard J. Hickey, Ph.D., senior research investigator, department of statistics, The Wharton School, University of Pennsylvania, Philadelphia
19. Robert Casad Hockett, Ph.D., research director, Council for Tobacco Research-USA, Inc., New York
20. Duncan Hutcheon, M.D., Ph.D., professor of pharmacology and medicine, College of Medicine and Dentistry of New Jersey, Newark
21. Leon O. Jacobson, M.D., physician-scientist emeritus, University of Chicago; chairman, Scientific Advisory Board, Council for Tobacco Research- USA, Inc., New York
22. Lawrence L Kupper, PhD., professor of biostatistics, School of Public Health, University of North Carolina, Chapel Hill
23. Hiram T. Langston, M.D., clinical professor of surgery (emeritus), Northwestern University Medical School; chairman, department of surgery, St. Joseph's Hospital, Chicago
24. Mariano F. La Via, M.D., professor of laboratory medicine and director, division of diagnostic immunology, Medical University of South Carolina
25. Stephen C. Littlechild, Ph.D., professor of commerce, head of department of industrial economics and business studies, Faculty of Commerce and Social Science, University of Birmingham, England
26. Eleanor J. Macdonald, professor emeritus of epidemiology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston.
27. Harold Mendelsohn, Ph.D., director, Center for Mass Communications Research and Policy, University of Denver
28. L.G.S. Rao, Ph.D., senior biochemist, Bellshill Maternity Hospital, Glasgow, Scotland
29. Jay Roberts, Ph.D., professor and chairman, department of pharmacology, Medical College of Pennsylvania, Philadelphia
30. Henry Rothschild, M.D., Ph.D., professor of medicine and anatomy, School of Medicine, Louisiana State University, New Orleans
31. Henry I. Russek, M.D., private practice of cardiology, Boca Raton, Fla.; formerly director of cardiovascular research, U S. Public Health Service Hospital, Staten Island
32. Bernice C. Sachs, M.D., psychiatrist, Cooperative Plan, Seattle
33. John E. Salvaggio, M.D., chairman and Henderson professor, department of medicine, Tulane Medical School, New Orleans
34. Gerhard N. Schrauzer, Ph.D., professor of chemistry, University of California, San Diego
35. Carl C. Seltzer, Ph.D., honorary research associate, Peabody Museum, Harvard University, Cambridge, Mass.
36. Sheldon C. Sommers, M.D., clinical professor of pathology, College of Physicians and Surgeons, Columbia University; scientific director, Council for Tobacco Research-USA, Inc., New York
37. Charles D. Spielberger, Ph.D., psychology professor, director, Center for Research in Community Psychology, University of South Florida, Tampa
38. Theodor D. Sterling, Ph.D., university research professor, Simon Fraser University, Burnaby, British Columbia
39. Bea J. van den Berg, M.D., director, child health and development studies, School of Public Health, University of California, Berkeley

[Every name on this list is a dedicated, long-term tobacco-friendly scientist, who persisted in working for the tobacco industry many years passed the time when it was still remotely possible for the gullible, or the stupid, to still believe that cigarettes were 1) not addictive 2) not a health hazard to smokers 3) not a health hazard to non-smokers.]

1984 Feb 20: -22 The INFOTAB Advisory Group (AG) meeting in Brussels. They are working on some of the basics still.

• setting up the Developing Countries Strategy Group (DCSG) and working out ... which countries.
• the strengthing of existing NMAs
• A public/"passive" smoking proposal (but INFOTAB not to fund research) Those involved were Wilfried Demback (RJR), David Wescott (Imperial), Helmut Gaisch (PMI), Jeff Felton (ex-BAT, now doing work for INFOTAB).
• Unanimous agreement on Bryan Simpson as Chairman
• "Rylander Symposium" report on ETS has been published and will be sent to all major universities and medical libraries around the world (approx 1200 copies)
• The "Bavarian Workshop" will be held in March, with publication of results in Fall. (English and German)
• A video if Ingo Walter making the same presentation as was give at the Board Of Directors meeting in Bath will be ready with the next few weeks, and will be shown at the Latin America NMA Workshop in Miami, March 20-22.
• Sir Ronald Radford is available as an INFOTAB tax consultant. He was Sec-Gen of the Customs Cooperation Council.
• Professors [Stephen] Littlechild and [Jack] Wiseman are in the process of preparing a second and more comprehensive paper on government regulatory policy. (Second wider than just smoking)
• Considerable support for exploring how more use could be made of the MRFIT study.
• INFOTAB's profile (media coverage) — if it became an identifiable source of information it might be difficult to limit the types of inquiries made to it.
• Bryan Simpson asked to speak at World Tobacco Symposium. As this is primarily an industry gathering the risk of over-expsoure of INFOTAB was considered minimal
• Richard Corner heads the Middle East and West Africa working groups
• Expansion of the CATAC Five Arguments booklet. Need clearance by AG. Also need £6—8,000.

1984 Oct: Ph.D. Professor of Commerce Head of Department Department of Industrial Economics and Business Studies Faculty of Commerce and Social Science The University of Birmingham, London

1984 Feb 16: Draft outline of the Book to be derived from Smoking and Society conference (June 1984 New York) and edited by Tollison. INFOTAB to distribute.

Smoking, Market Failure, and Cost-Benefit Analysis (Littlechild)
The anti-smoking pressure group differs from other pressure groups only in the intensity of its campaign. In reflects a general human propensity to attempt to regulate the activities of other people.

    Nowadays, there is increasing awareness that regulation typically benefits products rather than consumers. In consequence, regulators are generally on the retreat. However, the move towards deregulation has not yet encompassed those areas, such as smoking, where the product is alleged to have deleterious effects on consumers themselves or on persons associated with consumers.

    The purpose of this paper is to explore the reasons for continued government regulation in these areas, and to investigate whether these reasons are good ones. More specifically, we consider the various arguments put forward by the anti-smoking interests, and assess whether these are valid grounds for further government regulation of the use of tobacco.

1984 June 8: A study by economist, SC Littlechild "Smoking and Market Failure" (revised in October 1984), mentions a paper on smoking in restaurants, co-written by Shughart and Tollison

    It was originally presented at a Smoking and Society Conference, in New York, June 1984 and has been revised for further use.

1983 Sep: Helping Infotab in economic arguments ++++ p200 NMA WORKSHOP WASHINGTON [830919-830922] [690156036/6276]

1982 Mar 13: B Com and PhD Profesor of Commerce Uni of Birmingham Pro-industry statements [2025417978]

Key consultant in preparation of ICOSI Social Cost/Social benefits document see p3 ICOSI-SOCIAL COST/SOCIAL VALUE PAPERS. [502091507/1510]

1982 Aug 31: SC Littlechild, Special Projects A/C [03638775]

1984 Apr: Prof Stephen Littlechild (Uni of Birmingham) and Prof Jack Wiseman (Uni of York) writing "Principles of Public Policy relevant to Smoking" - appeared in Journal of the Policy Studies Institute of London

    A note about above paper says that it was commissioned in April 83 to be presented to an economics journal "If the paper is acceptable to us." See [503653691/3699]

1983 May 5: -12 Hearings before the Committee on Labor and Human Resources. US Senate, 98th Congress, First Session. on S 772,

1981 Jan 7: INFOTAB's SAWP Committee's Progress Report onSocial Costs/Social Values. It reports that"

• Tollisson and Wagner have requested financial support in preparing a monograph for publication.
• There is a Tobacco Institute (of US) report by Witonski for publication
• Mentions George Berman and Sherwin Feinhandler, Peter Berger, Stephen Littlechild, Alan Woodfield, Aaron Wildavsky, and the company AT Kearney.
• It asks "Through what organisation/s will ICOSI sponsor the Wharton Conference?"

1981 May 18: Speaking at Wharton School Applied Research conference on "social cost"

1984 June 8: A study by the UK economist, SC Littlechild "Smoking and Market Failure", mentions a paper on smoking in restaurants, which had been co-written by Shughart and Tollison

    The LittleChild study was originally presented at a Smoking and Society Conference, in New York, June 1984 and has been revised in October 1984 for further use by the Tobacco Institute.

CONTRIBUTORS:hrh2 scsu jrtm